8-K: IT Tech Packaging Gets Listing Extension to April 2027

IT Tech Packaging has secured an extension from NYSE American until April 15, 2027, to regain compliance with listing standards by filing delayed financial reports.

Summary

• IT Tech Packaging, Inc. (ITP) received notification from NYSE American that it is not in compliance with continued listing standards due to failure to file its 2025 Form 10-K and its 2026 Forms 10-Q for the quarters ended March 31 and June 30.
• The company submitted an extension request on October 1, 2026, and on October 7, 2026, NYSE Regulation granted an extension plan period through April 15, 2027 (New Cure Deadline) to complete these delayed filings.
• The company's common stock will continue to be listed on NYSE American during this period, subject to compliance with the plan and other listing requirements, and will carry a '.LF' late filer indicator.
• If the company fails to make progress consistent with the plan or does not complete the filings by the New Cure Deadline, NYSE staff will initiate delisting proceedings.
• A press release announcing this situation and the extension was issued on October 9, 2026.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development due to the continued non-compliance with listing standards and the potential for delisting, despite the granted extension.

Positives

• NYSE American has granted an extension until April 15, 2027, allowing the company more time to file its delinquent reports.
• The company's common stock will continue to be listed and traded on NYSE American during the plan period, avoiding immediate delisting.
• The company is actively working to complete the delayed filings and expects to file them by the New Cure Deadline.

Negatives

• The company is not in compliance with NYSE American continued listing standards due to failure to file its 2025 Form 10-K and 2026 Forms 10-Q.
• Failure to meet the plan milestones or file by April 15, 2027, will result in the initiation of delisting proceedings.
• The company's stock will continue to bear a '.LF' late filer indicator until the delinquency is cured.

Risks

• The company may not be able to complete the delayed filings by the April 15, 2027 deadline.
• The company may not make progress consistent with the plan during the extension period.
• The company may not regain compliance with NYSE American continued listing standards.
• Delisting proceedings may be initiated if the company fails to meet the terms of the extension plan.
• There can be no assurance that the company will be able to cure the filing delinquency within the extended period.

Future Outlook

The company expects to file its delayed reports on or before April 15, 2027. However, there is no assurance that these filings will be completed within this period or that the company will regain compliance with NYSE American continued listing standards.

Management Comments

• The Company is working diligently to complete the Delayed Filings and currently expects to file them on or before the New Cure Deadline; however, there can be no assurance that the Delayed Filings will be completed within such period or that the Company will regain compliance with the NYSE American continued listing standards.

Industry Context

StockSavvy.ai notes that frequent late filings and non-compliance with exchange listing standards can erode investor confidence and signal potential underlying operational or financial issues within a company. This situation is particularly concerning for companies listed on major exchanges like NYSE American, which have stringent requirements.

Stakeholder Impact

• Shareholders: Potential negative impact on stock price due to non-compliance and risk of delisting; continued uncertainty until filings are made.
• Creditors: Increased risk perception due to potential delisting and operational uncertainties.
• Employees: Potential impact on morale and job security if delisting leads to significant financial distress.
• Regulators (SEC and NYSE American): Continued scrutiny and potential enforcement actions if compliance is not achieved.

Next Steps

• Complete the delayed filings (Form 10-K for 2025 and Forms 10-Q for Q1 and Q2 2026) by April 15, 2027.
• Make progress consistent with the plan submitted to NYSE Regulation.
• Regain compliance with NYSE American continued listing standards.
• Avoid initiation of delisting proceedings.

Key Dates

Recommendation

The company has been granted an extension to cure its listing deficiencies, which temporarily avoids delisting. However, the significant delays in filing financial reports and the ongoing risk of delisting create substantial uncertainty. A 'hold' recommendation reflects the need for investors to await the timely filing of financial statements and evidence of progress towards regaining compliance before considering any further action.

Keywords

Listing Standards, Delisting, SEC Filings, Form 10-K, Form 10-Q, Extension Request, Late Filer, NYSE American